Next Quarterly Earnings
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Tango Therapeutics is a US-based biotechnology company specializing in the development of innovative cancer therapies. By utilizing targeted synthetic lethality approaches, the company identifies novel drug candidates to treat challenging tumor types and address significant unmet medical needs.
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Tango Therapeutics is scheduled to report its next quarterly earnings on 11/10/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Tango Therapeutics last reported quarterly earnings on 8/11/2026 (Q2 2026). Earnings per share (EPS) came in at -0.37 USD.
Tango Therapeutics has beaten analyst EPS estimates in 2 of its last 5 evaluated quarters (beat rate: 40%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.